What is it about?
A contribution to the growing research area of developing combined or combinable contrast agents or tracers that can be detected with multiple imaging modalities, providing complementary gain in information.
Featured Image
Read the Original
This page is a summary of: Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents, Pharmaceuticals, November 2021, MDPI AG,
DOI: 10.3390/ph14111155.
You can read the full text:
Contributors
The following have contributed to this page
